Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

iBio (IBIO) Gross Profit (2020 - 2022)

Historic Gross Profit for iBio (IBIO) over the last 4 years, with Q2 2022 value amounting to $46000.0.

  • iBio's Gross Profit fell 8486.84% to $46000.0 in Q2 2022 from the same period last year, while for Jun 2022 it was $2.2 million, marking a year-over-year increase of 5782.96%. This contributed to the annual value of $2.2 million for FY2022, which is 13839.38% up from last year.
  • According to the latest figures from Q2 2022, iBio's Gross Profit is $46000.0, which was down 8486.84% from $1.9 million recorded in Q1 2022.
  • In the past 5 years, iBio's Gross Profit registered a high of $1.9 million during Q1 2022, and its lowest value of $10000.0 during Q1 2020.
  • Moreover, its 3-year median value for Gross Profit was $287500.0 (2020), whereas its average is $437100.0.
  • Data for iBio's Gross Profit shows a peak YoY increase of 262000.0% (in 2021) and a maximum YoY decrease of 8886.64% (in 2021) over the last 5 years.
  • Quarter analysis of 3 years shows iBio's Gross Profit stood at $494000.0 in 2020, then crashed by 88.87% to $55000.0 in 2021, then decreased by 16.36% to $46000.0 in 2022.
  • Its last three reported values are $46000.0 in Q2 2022, $1.9 million for Q1 2022, and $55000.0 during Q4 2021.